CPRX FY 2021 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$141M+18.3% YoY

Gross Profit

$119M84.5% margin

Operating Income

$52M37.2% margin

Net Income

$39M28.0% margin

EPS (Diluted)

$0.37

Cash Flow

Operating Cash Flow

$60M

Free Cash Flow

$59M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$238M

Total Liabilities

$31M

Stockholders' Equity

$207M

Cash & Equivalents

$171M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$141M	$119M	+18.3%
Gross Profit	$119M	$102M	+16.6%
Operating Income	$52M	$41M	+26.8%
Net Income	$39M	$75M	-47.3%